about
Deep sequencing reveals novel microRNAs and regulation of microRNA expression during cell senescence.Ubiquinol decreases monocytic expression and DNA methylation of the pro-inflammatory chemokine ligand 2 gene in humans.Environmental and epigenetic effects upon preimplantation embryo metabolism and development.Cross Platform Standardisation of an Experimental Pipeline for Use in the Identification of Dysregulated Human Circulating MiRNAs.Adolescent idiopathic scoliosis (AIS), environment, exposome and epigenetics: a molecular perspective of postnatal normal spinal growth and the etiopathogenesis of AIS with consideration of a network approach and possible implications for medical thUbiquinol affects the expression of genes involved in PPARα signalling and lipid metabolism without changes in methylation of CpG promoter islands in the liver of mice.Whither the etiopathogenesis (and scoliogeny) of adolescent idiopathic scoliosis? Incorporating presentations on scoliogeny at the 2012 IRSSD and SRS meetings.Microarray expression profiling identifies genes with altered expression in Adolescent Idiopathic Scoliosis.Chimeric aptamers in cancer cell-targeted drug deliveryNon-coding transcription characterization and annotation: a guide and web resource for non-coding RNA databases.MicroRNAs in cancer diagnosis and therapy: from bench to bedside.MicroRNA promoter methylation: a new tool for accurate detection of urothelial carcinoma.Down-regulated serum microRNA-101 is associated with aggressive progression and poor prognosis of cervical cancer.miR-21 inhibition of LATS1 promotes proliferation and metastasis of renal cancer cells and tumor stem cell phenotype.siRNA-participated chemotherapy: an efficient and specific therapeutic against gastric cancer.Etiological Theories of Adolescent Idiopathic Scoliosis: Past and Present.
P2860
Q33921302-5FF09639-43E7-45D4-88F8-82CD10941AD2Q34424359-DCB4A922-18B2-4D36-923E-43197262DD9CQ35242537-0FD7C55D-D948-491B-A98A-F0AEB6DAA56DQ35768989-7E69748F-B8F6-4586-9A2C-E75ED813B075Q35800389-7A9484C6-8D41-4E0F-A120-E35F0B7DCA04Q35829449-83475684-2519-49AB-BDDE-C9F2EA0037F7Q36718750-B44CEC3B-11DB-4D64-98F6-CF2109F2F382Q36912828-F1DA5C8F-BB0C-4DDF-BFE4-B895BDFE44D7Q37939984-6879076D-4966-41BC-B65B-28C636F27922Q37984180-B4F2D937-8056-4327-AD31-FDDEAEF5E3A8Q38057979-AAABD9F5-2F32-4A37-BAEF-2D650A8DAAA3Q40383574-6EC6D13F-7E71-4F94-8687-78263B5A3500Q42700315-E6AB9D6A-C19E-4A5F-93F3-F80975BEA3F5Q43290522-696EDD91-D14E-4F8C-8649-983514DF0AB9Q43544239-AAD4921A-9A3D-4AB8-A78C-1EDFC3FDC8FFQ49334724-A72D1189-A3C0-4A62-A34A-0F66E7806AB9
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MicroRNAs, epigenetics and disease.
@en
MicroRNAs, epigenetics and disease.
@nl
type
label
MicroRNAs, epigenetics and disease.
@en
MicroRNAs, epigenetics and disease.
@nl
prefLabel
MicroRNAs, epigenetics and disease.
@en
MicroRNAs, epigenetics and disease.
@nl
P2860
P356
P1476
MicroRNAs, epigenetics and disease.
@en
P2860
P304
P356
10.1042/BSE0480165
P577
2010-09-01T00:00:00Z